Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gastrointestinal Cancers Congress 2024

Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer

Panel discussion

Date

28 Jun 2024

Session

Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer

Presenters

Thomas Seufferlein

Authors

T. Seufferlein1, A. Lamarca2, A. Ohba3, D. Melisi4, R. Obermannova5

Author affiliations

  • 1 University of Ulm, Ulm/DE
  • 2 Hospital Universitario Fundacion Jimenez Diaz, Madrid/ES
  • 3 NCCH - National Cancer Center Hospital-Tsukiji Campus, Tokyo/JP
  • 4 University of Verona, Verona/IT
  • 5 Masaryk Memorial Cancer Institute, Brno/CZ

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Thomas Seufferlein

Session: Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer

Resources:

Webcast

From evidence to clinical practice

Presenter: Davide Melisi

Session: Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer

Resources:

Webcast

Conclusion

Presenter: Thomas Seufferlein

Session: Servier - Pathways to enhance patients' benefits in metastatic pancreatic cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.